Gene · 6530
Papers3,539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,539
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Focused Review of the Metabolic Side-Effects of Clozapine. | Front Endocrinol (Lausanne) | 2021 | 33716966 | PubTator, text mining | PubMed |
| Cortical structural differences in major depressive disorder correlate with cell type-specific transcriptional signatures. | Nat Commun | 2021 | 33712584 | PubTator, text mining | PubMed |
| High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma. | Clin Cancer Res | 2021 | 33685867 | PubTator, text mining | PubMed |
| Evidence of Reduced Efferent Renal Sympathetic Innervation After Chemical Renal Denervation in Humans. | Am J Hypertens | 2021 | 33677553 | PubTator, text mining | PubMed |
| Kv1.5 channels are regulated by PKC-mediated endocytic degradation. | J Biol Chem | 2021 | 33676894 | PubTator, text mining | PubMed |
| Assessment of Epinephrine and Norepinephrine in Gastric Carcinoma. | Int J Mol Sci | 2021 | 33670813 | PubTator, text mining | PubMed |
| A survival of the fittest strategy for the selection of genotypes by which drug responders and non-responders can be predicted in small groups. | PLoS One | 2021 | 33667227 | PubTator, text mining | PubMed |
| Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma. | J Exp Pharmacol | 2021 | 33664600 | PubTator, text mining | PubMed |
| β2 and α2 adrenergic receptors mediate the proneurogenic in vitro effects of norquetiapine. | Neural Regen Res | 2021 | 33642392 | PubTator, text mining | PubMed |
| Microsleep disturbances are associated with noradrenergic dysfunction in Parkinson's disease. | Sleep | 2021 | 33608699 | PubTator, text mining | PubMed |
| Selective effects of serotonin on choices to gather more information. | J Psychopharmacol | 2021 | 33601931 | PubTator, text mining | PubMed |
Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. | J Child Adolesc Psychopharmacol | 2021 | 33600233 | PubTator, text mining | PubMed |
| Bicyclic Diazepinones as Dual Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels and the Norepinephrine Transporter. | J Med Chem | 2021 | 33591743 | PubTator, text mining | PubMed |
| Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. | Transl Psychiatry | 2021 | 33589590 | PubTator, text mining | PubMed |
| Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors. | Transl Psychiatry | 2021 | 33589583 | PubTator, text mining | PubMed |
| Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns. | Cell Mol Biol Lett | 2021 | 33588752 | PubTator, text mining | PubMed |
| Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults. | J Clin Psychopharmacol | 2021 | 33587403 | PubTator, text mining | PubMed |
| 123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis. | Ann Nucl Med | 2021 | 33586098 | PubTator, text mining | PubMed |
| Are the 50's, the transition decade, in choroid plexus aging? | Geroscience | 2021 | 33576945 | PubTator, text mining | PubMed |
| Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease. | Pharmaceuticals (Basel) | 2021 | 33573211 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6530/papers?page=46